mk 0663 has been researched along with Arthralgia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akhverdyan, YR; Polyakova, JV; Sivordova, LE; Zavodovsky, BV | 1 |
| Amaro, C; Ferreira, ML; Miroux-Catarino, A; Silva, L; Viana, I | 1 |
| Gammaitoni, A; Greenwald, M; Kvien, TK; Mehta, A; Peloso, PM; Wang, H | 1 |
| Caralli, ME; De Barrio Fernández, M; Pelta Fernández, R; Rojas Pérez-Ezquerra, P; Seoane Rodríguez, M | 1 |
| Becker, A; Dömkes, S; Hillen, U; Livingstone, E; Schadendorf, D; Zimmer, L | 1 |
| Navarra, S; Rubin, BR; Smugar, SS; Tershakovec, AM; Yu, Q | 1 |
4 trial(s) available for mk 0663 and Arthralgia
| Article | Year |
|---|---|
[Evidence of feasibility etoricoxib therapy in osteoarthritis in elderly patients].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Diclofenac; Drug Monitoring; Etoricoxib; Female; Humans; Male; Osteoarthritis, Hip; Osteoarthritis, Knee; Pain Management; Pyridines; Sulfones; Treatment Outcome | 2016 |
Do COX-2 inhibitors provide additional pain relief and anti-inflammatory effects in patients with rheumatoid arthritis who are on biological disease-modifying anti-rheumatic drugs and/or corticosteroids? Post-hoc analyses from a randomized clinical trial
Topics: Analgesics; Arthralgia; Arthritis, Rheumatoid; Biological Products; Colombia; Cyclooxygenase 2 Inhibitors; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Etoricoxib; Health Status; Humans; North America; Pain Measurement; Pyridines; Sulfones; Surveys and Questionnaires; Switzerland; Time Factors; Treatment Outcome | 2015 |
Panniculitis with arthralgia in patients with melanoma treated with selective BRAF inhibitors and its management.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Arthralgia; Disease Progression; Dose-Response Relationship, Drug; Drug Eruptions; Etoricoxib; Female; Humans; Imidazoles; Indoles; Lymphatic Metastasis; Melanoma; Middle Aged; Neoplasm Staging; Oximes; Panniculitis; Point Mutation; Proto-Oncogene Proteins B-raf; Pyridines; Skin Neoplasms; Sulfonamides; Sulfones; Vemurafenib | 2012 |
Association of baseline disease and patient characteristics with response to etoricoxib and indomethacin for acute gout.
Topics: Acute Disease; Adult; Arthralgia; Arthritis; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Resistance; Etoricoxib; Female; Gout; Gout Suppressants; Humans; Indomethacin; Male; Middle Aged; Pyridines; Sulfones | 2007 |
3 other study(ies) available for mk 0663 and Arthralgia
| Article | Year |
|---|---|
Bullous fixed drug eruption induced by etoricoxib, confirmed by patch testing, with tolerance to celecoxib.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Blister; Celecoxib; Drug Eruptions; Etoricoxib; Female; Humans; Middle Aged; Patch Tests | 2019 |
Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE) Caused by Etoricoxib.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Drug Eruptions; Etoricoxib; Exanthema; Female; Humans; Middle Aged; Osteoarthritis; Patch Tests; Pyridines; Sulfones | 2016 |
[Rapidly acting and powerful antirheumatic drug now also approved in Germany. Arcoxia (etoricoxib, MSD)]].
Topics: Acute Disease; Antirheumatic Agents; Arthralgia; Arthritis, Rheumatoid; Clinical Trials as Topic; Drug Approval; Etoricoxib; Gout; Humans; Indomethacin; Osteoarthritis; Pain Measurement; Pyridines; Sulfones | 2004 |